IceCure Signs Exclusive Distribution Agreement with Rise General Trading, LCC, Expanding Market Reach Across the Middle East
USA - English
News provided by
Share this article
Share this article
CAESAREA, Israel, Feb. 17, 2021 /PRNewswire/ IceCure Medical Ltd. (TASE: ICCM) ( IceCure or the Company ), developer of the next generation cryoablation technology that destroys tumors by freezing without the need for surgery, today announced an exclusive distribution agreement with Rise General Trading, LLC for IceCure s ProSense® Cryoablation System in the United Arab Emirates and Arabian Gulf States ( the territories ).
Under the terms of the agreement, Rise General Trading, LCC will purchase a minimum amount of approximately $16 million USD of IceCure s products over a period of three years. The first purchase order will be executed within three months after the receipt of all regulatory licenses necessary for the sale of IceCure s products in the first territory. Licenses req